Gilead Sciences GILD Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.5×+0.3×

IncyteINCY

4.6×+1.7×

ImmunityBio, Inc.IBRX

6.7×+4.4×

PrecigenPGEN

4.8×+1.3×

AnaptysBio, Inc.ANAB

7.6×-0.7×

Iovance Biotherapeutics, Inc.IOVA

3.6×-0.6×

FAQ

What is Gilead Sciences's current ratio?

Gilead Sciences (GILD) reported current ratio of 2× in Q1 2026.

How has Gilead Sciences's current ratio changed year-over-year?

Gilead Sciences's current ratio increased by 43.7% year-over-year, from 1.4× to 2×.

What is the long-term trend for Gilead Sciences's current ratio?

Over 5 years (2020 to 2025), Gilead Sciences's current ratio has grown at a 2.0% compound annual growth rate (CAGR), from 1.4× to 1.6×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.